Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Flushing, New York Clinical Trials

A listing of Flushing, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (41) clinical trials

People with non-small cell lung cancer are invited to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

4.5 miles

Learn More »

People with small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

4.5 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of RO6867461 in Participants With Diabetic Macular Edema (YOSEMITE)

This study will evaluate the efficacy, safety, and pharmacokinetics of RO6867461 administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).

Phase

5.14 miles

Learn More »

Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP-301)

This study consists of a 4-week screening period, a 24-week treatment period for all participants, followed by a 28-week treatment period extension (to 52 weeks in total) for a subset of at least 60 and up to 80 participants, and a 2-week post-treatment follow-up period. This is an outpatient study ...

Phase

5.2 miles

Learn More »

People with prostate cancer are asked to participate in a research study being conducted by Queens Hospital Center.

Phase N/A

5.2 miles

Learn More »

CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation

Using preoperative MRI imaging to identify areas suspicious of local advancement in addition to identifying areas with a higher likelihood of a positive margin during RP due to the presence of high risk features, Civasheet and its inherently flexible structure allow the sheet to be directly implanted on areas suspicious ...

Phase N/A

5.95 miles

Learn More »

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

This is an international, multicentre, parallel-group, event-driven, randomised, double-blind study in patients with HFpEF, evaluating the effect of dapagliflozin 10 mg versus placebo, given once daily in addition to background regional standard of care therapy, including treatments to control co-morbidities, in reducing the composite of CV death and heart failure ...

Phase

5.95 miles

Learn More »

Prophylactic NPWT to Reduce SSI in Colorectal Surgery

The purpose of this study is to see if the Negative Pressure Wound Therapy (NPWT) system is effective and safe for the prevention of superficial and deep incisional surgical site infections (SSI) in high risk patients within 30 days after elective colorectal surgery. It has been shown that patients with ...

Phase N/A

5.95 miles

Learn More »

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Phase A: A global, prospective, multicenter, 2:1 randomized trial evaluating the safety and effectiveness of the DES BTK Vascular Stent System compared to standard percutaneous transluminal angioplasty to treat infrapopliteal artery lesions in subjects with critical limb ischemia(CLI). Phase A RCT will begin with one size of the device: 3.5 ...

Phase

5.95 miles

Learn More »

The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial.

This is a Phase II trial evaluating the efficacy and safety of sequential pembrolizumab (200 mg every three weeks) and accelerated, dose-painted radiotherapy for patients with locally advanced NSCLC with PD-L1 expression 50%. Patients with PD-L1 expression < 50% will also be enrolled and treated with standard concurrent chemoradiotherapy to ...

Phase

6.68 miles

Learn More »